Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC

This study has been terminated.

( See Termination Reason in Detailed Description. )

Study NCT00313768 Information provided by Pfizer

First Received: April 10, 2006 Last Updated: September 24, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2008
Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: September 24, 2009